- HA Concentration
- 24 mg/mL
- Lidocaine
- 3 mg/mL
- Gel Texture
- Dense Monophasic
- Needle (incl. 2 ea)
- 30G × 13mm
- Elasticity Level
- +
- Viscoelasticity G′*
- 20–100 Pa
- Depth of Injection
- Superficial dermis
- Indication
- Fine lines, subtle volume
- Volume
- 1.0 mL
COLLECTION
New Arrivals
Explore our carefully curated categories. High-quality products sourced directly from trusted Korean manufacturers.
20 products
20 products
Sort by:
MUCHCAINE PLUS CREAM 100g
2200
$22.00
Unit price perMUCHCAINE PLUS CREAM 100g
2200
$22.00
Unit price per
Product Identification
MUCHCAINE PLUS CREAM
Topical Anesthetic Cream
Professional Use Lidocaine 100g Tube
Total Volume/Content
100g
Formulation Type
Topical anesthetic cream
Core Ingredients & Technology
Primary Active Ingredients
Lidocaine (High concentration)
Mechanism of Action
Lidocaine acts as a local anesthetic by temporarily blocking the pathway of pain signals along the nerves. It inhibits the influx of sodium ions through nerve cell membranes, preventing the generation and conduction of electrical impulses and resulting in a temporary numbing effect on the applied area.
Key Technical Features
Formulated for rapid skin penetration to provide effective superficial anesthesia prior to dermatological or aesthetic procedures.
Rapid Penetration Pain Blockade Superficial Anesthesia
Efficacy & Benefits
Main Effects
- Temporary local anesthesia.
- Skin numbing.
- Pain relief.
Recommended Areas of Use
Intact skin areas requiring pain management prior to procedures such as dermal filler injections, mesotherapy, MTS (Microneedling Therapy System), laser treatments, tattooing, waxing, and minor surgical procedures.
Usage Protocol
Application Method
Topical application.
Onset and Duration of Effect
- Onset: Typically takes effect within 15 to 30 minutes after application under occlusion.
- Duration: The numbing effect generally lasts for 1 to 2 hours after the cream is removed, depending on the individual's skin type and application duration.
Application & Preparation Instructions Clean and dry the application site thoroughly before use. Apply an even, moderate layer of the cream to the target intact skin area. To maximize absorption and efficacy, cover the applied area with an occlusive dressing (e.g., plastic wrap).
Crucial step: Completely wipe off and cleanse all residual cream from the skin before initiating any procedure that breaks the skin barrier.
Crucial step: Completely wipe off and cleanse all residual cream from the skin before initiating any procedure that breaks the skin barrier.
Storage & Handling
Storage Conditions
Store at room temperature (1–30°C) in an airtight container.
General Handling Tips
Keep out of reach of children. Protect from direct sunlight and do not freeze. Keep the cap tightly closed when not in use to prevent the cream from oxidizing or drying out.
Safety Information
Contraindications Do not use on patients with known hypersensitivity to amide-type local anesthetics. Contraindicated for use on broken skin, open wounds, burns, or mucous membranes. Pregnant or breastfeeding women should consult a physician prior to use.
Safety Warnings For external use only. Avoid contact with the eyes. Do not apply over excessively large areas of the body or leave the cream on for an extended period (beyond recommended times) to prevent the risk of systemic toxicity (e.g., lidocaine toxicity).
Common Temporary Side Effects
Mild erythema (redness), localized swelling, itching, or blanching (whitening) of the skin at the application site.
Post-Treatment Care
- Ensure the skin is completely clear of the cream before beginning any invasive procedure.
- Monitor for any signs of allergic reaction post-procedure.
Keywords
MUCHCAINE PLUS CREAM Topical Anesthetic Numbing Cream Lidocaine Cream Pain Relief MTS Numbing Tattoo Cream Laser Prep Aesthetics Prep
REVELINA (FINE / DEEP / SUB-Q)
2500
$25.00
Unit price perREVELINA (FINE / DEEP / SUB-Q)
2500
$25.00
Unit price per
Fine
Deep
Sub-Q
Cross-Linked Hyaluronic Acid Filler · 24 mg/mL · With Lidocaine
Re-veiled definition.
Manufactured by AQUABANK Inc. · Seoul, Korea · B2B Product Range — FINE · DEEP · SUB-Q
The Range
Dense Monophasic HA Fillers
Soft texture without compromising shape retention.
Revelina offers three cross-linked HA fillers for aesthetic correction across the face — FINE, DEEP, and SUB-Q — formulated from non-animal origin, dense monophasic hyaluronic acid. Each line is matched to a placement depth and indication, from superficial fine lines to deep, structural volume.
FINE
30G · Superficial dermis
Fine lines and subtle volume — uniform particle distribution for superficial placement.
DEEP
27G · Mid-to-deep dermis
Mid-volume and contour — mid-dermal placement for fuller, defined structure.
SUB-Q
25G · Deep / subcutaneous
Structural lift and high-volume augmentation — deep placement for lasting definition.
Sterile, pyrogen-free viscoelastic gel of cross-linked non-animal origin HA. With Lidocaine. 1.0 mL pre-filled glass syringe.
Composition
Hyaluronic Acid
24 mg/mL
Cross-linked · non-animal origin
Lidocaine HCl
3 mg/mL
With lidocaine
Phosphate buffer
q.s.
Buffering
24 mg/mL
HA Concentration
1.0 mL
Pre-filled Volume
3
Injection Depths
≤ 2 ppm
Residual BDDE
10,000
Cleanroom Class
Representative figures. Residual BDDE within the KFDA standard (≤ 2 ppm) — actual values per OEM Certificate of Analysis.
Why Revelina
Four points of difference
Material and handling characteristics that define every Revelina line.
01
Ultra-Low BDDE
MCO™ Technology minimises residual cross-linking agent.
02
Constant Injection Force
Uniform particles for a consistent, controlled extrusion feel.
03
Dense Monophasic
A homogeneous gel — soft on delivery, stable in shape. Not a particulate biphasic filler.
04
Optimized Viscoelasticity
Stable cross-linking for predictable handling.
Benefits
What Revelina delivers
The clinical and handling benefits that carry across every line.
Long-lasting effect
Stable cross-linking sustains correction over time.
Suitable for sensitive skin
Non-animal origin HA with ultra-low residual BDDE.
Improvement of complexion
Restores hydration and surface smoothness.
Short recovery period
Minimal downtime after a controlled procedure.
Correction at every depth
FINE, DEEP and SUB-Q cover fine lines to deep volume.
Comfortable injection
Formulated with lidocaine for a comfortable injection.
Even distribution of HA gel
Dense monophasic gel spreads uniformly under the skin.
Optimal HA concentration
24 mg/mL balanced for lift and a natural feel.
Low irritation profile
Purified, sterile, pyrogen-free formulation.
Illustrative comparison for orientation only.
How Revelina compares
01
Injection force
Smooth, consistent extrusion feel.
02
Moulding strength
Holds its sculpted shape after placement.
03
Stability
Resists degradation for lasting correction.
04
Safety
Purity, ultra-low residual BDDE, tolerability.
05
Convenience
Ready-to-use with predictable handling.
06
Viscoelasticity
Balanced elasticity for a natural result.
Filler B / C / D denote anonymised market references; axis values are representative and do not constitute a head-to-head clinical claim.
Specifications
Line specifications
|
FINE
|
DEEP
|
SUB-Q
|
|
|---|---|---|---|
| HA Concentration | 24 mg/mL | 24 mg/mL | 24 mg/mL |
| Lidocaine | 3 mg/mL | 3 mg/mL | 3 mg/mL |
| Gel Texture | Dense Monophasic | Dense Monophasic | Dense Monophasic |
| Needle (incl. 2 ea) | 30G × 13mm | 27G × 13mm | 25G × 13mm |
| Elasticity Level | + | + + | + + + |
| Viscoelasticity G′* | 20–100 Pa | 101–200 Pa | 201–300 Pa |
| Depth of Injection | Superficial dermis | Mid-to-deep dermis | Deep dermis / subcutaneous |
| Indication | Fine lines, subtle volume | Mid-volume, contour | Structural lift, high-volume |
| Volume | 1.0 mL | 1.0 mL | 1.0 mL |
Each Box
1.0 mL pre-filled glass syringe ×1 · EO-sterilized single-use needles ×2 (line gauge) · Instructions for use.
*G′ values are reference estimates; actual values per OEM Certificate of Analysis. Needles are EO-sterilized, single-use. Duration of effect varies by individual, injection technique and area treated.
Line Characteristics
Viscoelasticity & gauge
How the three lines differ in elasticity and delivery.
Viscoelasticity G′ — reference estimate
FINE
20–100 Pa
DEEP
101–200 Pa
SUB-Q
201–300 Pa
Scale 0–300 Pa. G′ values are reference estimates · per OEM Certificate of Analysis.
Included needle gauge — 13 mm common
30G
13 mm · ×2
27G
13 mm · ×2
25G
13 mm · ×2
Bar thickness indicates relative needle bore (30G finest → 25G widest). EO-sterilized, single-use.
Technology
MCO™ Technology
Minimising Cross-linking agent by Optimising reaction.
The cross-linking agent connects HA chains into a stable network. By optimising the reaction conditions, MCO™ Technology maximises cross-linking efficiency while minimising the amount of residual cross-linking agent.
Ultra-Low BDDE — residual cross-linking agent
KFDA standard (limit)
< 2 ppm
Revelina · representative
≤ 2 ppm
Representative comparison — residual BDDE minimised via MCO™ Technology and held within the KFDA standard. Actual values per OEM Certificate of Analysis.
Revelina
viscosity & elasticity chart
Placement Guide
Injection site by line
Recommended placement across facial zones.
FINE
Forehead · Glabella · Tear trough · Crow's feet · Perioral · Fine lines
DEEP
Nasolabial folds · Lips · Cheekbones · Marionette lines · Mid-face · Temple
SUB-Q
Cheeks · Chin · Jawline · Facial oval · Mandibular angle · Deep volume
Injection depth — surface to deep
FINE
Superficial dermis
Fine lines · subtle volume
DEEP
Mid-to-deep dermis
Mid-volume · contour
SUB-Q
Deep / subcutaneous
Structural lift · volume
Schematic. Recommended placement only — area suitability is determined by the treating practitioner.
Manufacturing & Quality
Made by a specialist HA manufacturer
Revelina is produced by AQUABANK Inc., a licensed medical-device manufacturer specialising in HA-based dermal solutions, based in Seoul, Korea. Manufactured in a controlled Cleanroom Class 10,000 environment.
Certification
ISO 13485:2016
Medical Devices QMS · G-CERTI
License
MFDS Manufacturing
Manufacturing License (Korea)
Export
Free Sales
Certificate of Free Sales · MFDS · export-ready
Quality control
Every production lot is released against a Certificate of Analysis — documented unit by unit. Tested for: appearance, identification, pH, HA assay, residual BDDE, viscoelasticity, osmolality, sterility and endotoxin.
~24 mg/mL
HA
≤ 2 ppm
Residual BDDE · KFDA std.
≤ 0.5 EU/mL
Endotoxin
~7
pH
Sterile
Pyrogen-free
Representative ranges for orientation. Actual values per the OEM Certificate of Analysis issued with each lot.
Cross-Linked Hyaluronic Acid Filler · 24 mg/mL · With Lidocaine
Re-veiled definition.
Fine
Deep
Sub-Q